4 - 29 - PITYRIASIS RUBRA PILARIS Flashcards
most common subtype and occurs in more than 50% of all cases
Type I (classic adult)
diagnostic hallmark of PRP
sharply demarcated islands of unaffected skin (“nappes claires”)
It is characterized by its atypical morphologic picture and a long duration of more than 20 years.
Type II (atypical adult)
clinical picture resembles ichthyosiform scaling, areas of follicular hyperkeratosis, and sparseness of the scalp hair
The cephalocaudal progression observed in type I is missing, and there is less tendency for the patients to develop erythroderma.
Type II (atypical adult)
affects 10% of PRP patients, with the onset usually between the ages of 5 and 10 years
Type III (classic juvenile)
This type usually manifests in prepubertal children and young adults
Type IV (circumscribed juvenile)
characterized by well-demarcated hyperkeratotic erythematous plaques on the elbows and knees, resembling localized psoriasis
Type IV (circumscribed juvenile)
Palmoplantar keratoderma is characteristic for this type of PRP
Type IV (circumscribed juvenile)
characterized by an early age of onset and a chronic course
Type V (atypical juvenile) PRP
This type harbor a gain-of-function mutation in the CARD14 gene encoding the Caspase Recruitment Domain family member 14 (CARD14)
Type V (atypical juvenile) PRP
**Some patients present with scleroderma-like features affecting hands and feet.
Type V (atypical juvenile) PRP
This type is associated with acne conglobata, hidradenitis suppurativa, and lichen spinulosus
type VI (HIV-associated)
Often resolves within an average of 3 years
Type I (classic adult)
The only type of PRP presenting with localized distribution
Type IV ( Circumscribed Juvenile)
Similar to type I but appears in years 1 or 2 of life
Type III (Classic Juvenile)
most familial cases belong to this type
Type V (Atypical Juvenile)
symmetrically distributed lesions of the extensor surfaces frequently progress to erythroderma
Type VI (HIV-associated)
Characteristic histopath findings of PRP
alternating horizontal and vertical parakeratosis and orthokeratosis in a **checkerboard pattern,** hypergranulosis, thickening of the rete ridges, follicular hyperkeratosis, lack of neutrophilic infiltration, and limited vascular dilatation
First-line topical Meds for PRP
■ Emollients (water-in-oil emulsion)
■ Keratolytics (salicylic acid, urea)
■ Vitamin D 3 (calcipotriol)
generally serve as the first-line therapy in patients with PRP
Oral retinoids
first line systemic medications for PRP
■ Retinoids (0.5-0.75 mg/kg acitretin/day)
■ Methotrexate (10-25 mg weekly or higher)
■ Antiretroviral therapy (HIV-associated variant)
Second line treatment for PRP
Characterize Type I (classic adult PRP)
- Characteristically, type I PRP starts with erythematous macules forming patches and with follicular hyperkeratotic papules on the upper half of the body.
- As the disease evolves, a yellow-orange, scaling dermatitis often spreads to a generalized erythroderma over a period of 2 to 3 months
Frequently patients develop a waxy, diffuse, yellowish keratoderma of the palms and soles
Type I (classic adult)